These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 17622488

  • 1. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
    Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y.
    J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
    [Abstract] [Full Text] [Related]

  • 2. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk.
    Langholm LL, Rønnow SR, Sand JMB, Leeming DJ, Tal-Singer R, Miller BE, Vestbo J, Karsdal MA, Manon-Jensen T.
    Int J Chron Obstruct Pulmon Dis; 2020 Oct; 15():543-552. PubMed ID: 32210548
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.
    Jin Y, Zhu K, Wu S, He S, Cao C.
    Int J Chron Obstruct Pulmon Dis; 2024 Oct; 19():2273-2283. PubMed ID: 39416877
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria.
    Verrotti A, Greco R, Basciani F, Morgese G, Chiarelli F.
    Pediatr Res; 2003 Mar; 53(3):382-6. PubMed ID: 12595584
    [Abstract] [Full Text] [Related]

  • 5. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients.
    Polosa R, Malerba M, Cacciola RR, Morjaria JB, Maugeri C, Prosperini G, Gullo R, Spicuzza L, Radaeli A, Di Maria GU.
    Intern Emerg Med; 2013 Oct; 8(7):567-74. PubMed ID: 21660493
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria in chronic obstructive pulmonary disease.
    Kömürcüoğlu A, Kalenci S, Kalenci D, Kömürcüoğlu B, Tibet G.
    Monaldi Arch Chest Dis; 2003 Oct; 59(4):269-72. PubMed ID: 15148835
    [Abstract] [Full Text] [Related]

  • 7. Assessment of endothelial dysfunction by measuring von Willebrand factor and exhaled nitric oxide in patients with chronic obstructive pulmonary disease.
    Maricić L, Vceva A, Visević R, Vcev A, Milić M, Serić V, Fijacko V.
    Coll Antropol; 2013 Dec; 37(4):1153-60. PubMed ID: 24611328
    [Abstract] [Full Text] [Related]

  • 8. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [Abstract] [Full Text] [Related]

  • 9. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
    Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H.
    Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
    [Abstract] [Full Text] [Related]

  • 10. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY, Lowe GD, Rumley A, Dunn FG.
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [Abstract] [Full Text] [Related]

  • 11. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
    Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY.
    Ophthalmology; 2001 Apr; 108(4):705-10. PubMed ID: 11297487
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y, Suo L, Yu H, Wang C, Tang H.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [Abstract] [Full Text] [Related]

  • 13. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA, El-Meligi AA, Abdel-Hamid M, Elhendy A.
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [Abstract] [Full Text] [Related]

  • 14. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY, Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY.
    Int J Cardiol; 2007 Jun 25; 119(1):80-2. PubMed ID: 17027106
    [Abstract] [Full Text] [Related]

  • 15. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D, Tsiandoulas A, Pangalou M, Koutoupa E, Rozi P, Protopappa M, Barboutis K.
    Med Sci Monit; 2006 Feb 25; 12(2):CR55-62. PubMed ID: 16449948
    [Abstract] [Full Text] [Related]

  • 16. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD.
    Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ.
    Chest; 2010 Jul 25; 138(1):47-51. PubMed ID: 20154074
    [Abstract] [Full Text] [Related]

  • 17. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
    Goldsmith IR, Blann AD, Patel RL, Lip GY.
    Am J Cardiol; 2000 May 15; 85(10):1218-22. PubMed ID: 10802004
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
    Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, Bortoloso E, van Hinsbergh VW, Crepaldi G, Nosadini R.
    Diabetologia; 1998 Feb 15; 41(2):233-6. PubMed ID: 9498659
    [Abstract] [Full Text] [Related]

  • 19. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A, Powell JT, Lowe GD.
    J Vasc Surg; 2006 Mar 15; 43(3):474-80. PubMed ID: 16520158
    [Abstract] [Full Text] [Related]

  • 20. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
    Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC.
    Am J Respir Crit Care Med; 2008 Dec 15; 178(12):1211-8. PubMed ID: 18836149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.